Developers: | Food and Drug Administration (FDA - the Food and Drug Administration) |
Date of the premiere of the system: | December, 2019 |
Branches: | Pharmaceutics, medicine, health care |
2019: Start of global Internet storage for information exchange about difficult infectious diseases
At the beginning of December, 2019 the global Internet storage CURE ID which will allow clinical community to exchange data on infectious diseases hard to cure and on experience of use of new drugs was started.
The storage became result of cooperation between the Food and Drug Administration of the USA (FDA) and the National center of development of cross-disciplinary scientific research (NCATS). CURE ID allows to systematize and analyze experience of treatment of little-known tropical diseases, new infectious threats and also the infections caused by microorganisms, steady against antimicrobial medicines. The storage fixes all results of treatment when drugs were used according to new indications, in new populations, in new doses or in new combinations. The similar analysis can significantly simplify search of new use of already known drugs, and the application will become a link between large health centers, erudite, private practicians, public institutions and other health workers from around the world.
Systematic collection of information will help to reveal the drugs requiring additional studying, will stimulate further development of medicines and can be a source to information for other infectiologists in complex cases when treatment options with the set security and efficiency are absent. Besides, the application can form base for studying of the diseases which were earlier considered as absolutely incurable.
The application includes a news feed, function of search with a possibility of the choice from 325 different infectious diseases and syndromes and also the initial database from nearly 1500 clinical cases received from the published literature and 18,000 clinical trials.[1]